Viatris And Sandoz May Market Injectafer Generic In US From 2026
ANDA Disputes Regarding Ferric Carboxymaltose Are Now Settled
Viatris’ Mylan unit and Sandoz will have licenses to market generic ferric carboxymaltose products in the US from 1 July 2026 • Source: Alamy 
